-
Study aim
-
In this study, the therapeutic effects of Monavvem capsule versus placebo on chronic insomnia with high prevalence, physical complications and significant sociao-economical burden are studied.Thus, changes in mental quality of sleep, latency in sleep, sleep time, sleep efficiency, sleep disorders, need for sleep medication, patient daily function, ISI, PSQI, HAM-A, HAM- D is measured.
-
Design
-
Control group, groups, blind, randomized Clinical trials
-
Settings and conduct
-
Chronic insomnia patients are evaluated in sleep clinic based on DSM-5 and ICSD3 criteria and inform consent form. Subjects completed HAM-A, HAM-D, PSQI, and ISI questionnaires. Patients are randomly divided into two groups of placebo and placebo and randomly divided into two groups.In this study, 224 capsules or placebo were given to each group for eight weeks(4 capsules per day divided into 2 capsules each evening and 2 capsules each night before bedtime with a distance from the meal).The completed questionnaires will be completed in the fourth and eighth weeks.Patients are advised to complete the daily sleep information form at home.
-
Participants/Inclusion and exclusion criteria
-
Inclusion Criteria:Individuals aged 18 to 65 with the diagnosis of insomnia; ISI Score more than 7; no history of severe drug reaction to certain types of herbal medicines found in the drug; without using sleep aid medication in a week ago; Patients with the oral or written informed consent.Exclusion criteria: severe organic or psychiatric diseases as Parkinson's, Alzheimer's; alchohol or substance abuse; any other medication use or their withdrawal which affects sleep; history of blood coagulation disorders; other sleep disorders; pregnancy and lactation
-
Intervention groups
-
Drug group and placebo group
-
Main outcome variables
-
Severity index Insomnia, Total score of Pittsburgh, Hamilton's Anxiety Rating, Hamilton's Depression Scale Questionnaires